Oncogenic conversion of kinases involved in the MAPK (mitogen activated protein kinases) and PI3K (phosphatidyl-inositol-3-kinase)/AKT signaling cascades occurs in thyroid cancer [1–4]. The gene discussed is AKT1; the disease is thyroid gland carcinoma.